Institutional Ownership Kymera Therapeutics, Inc. (KYMR)
This table provides information about the institutional ownership of Kymera Therapeutics, Inc. (KYMR). We have compiled data on the 223 institutions that hold shares in the stock, with a total of 73.9 Million shares, which have been reported (via 13F filing form) to have a value of $4.8 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
6,651,429
shares
|
$432 Million
3.07% of portfolio
|
Q2 2025
Added 10.93%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
6,350,000
shares
|
$412 Million
4.91% of portfolio
|
Q3 2025
Reduced 3.14%
|
|
|
Bvf Inc
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
5,502,710
shares
|
$357 Million
16.85% of portfolio
|
Q2 2025
Added 6.6%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
5,421,722
shares
|
$352 Million
0.0% of portfolio
|
Q3 2025
Reduced 3.53%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
5,195,691
shares
|
$337 Million
0.05% of portfolio
|
Q3 2025
Reduced 3.28%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
5,097,378
shares
|
$331 Million
0.03% of portfolio
|
Q3 2025
Reduced 25.69%
|
|
|
Atlas Venture Life Science Advisors, LLC
|
Nov 13, 2025 Q3 2025 |
4,896,462
shares
|
$318 Million
62.55% of portfolio
|
Q3 2024
Reduced 8.48%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,155,429
shares
|
$270 Million
0.0% of portfolio
|
Q2 2024
Added 13.67%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2025 Q3 2025 |
3,428,150
shares
|
$223 Million
7.59% of portfolio
|
Q2 2025
Added 5.8%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
2,019,454
shares
|
$131 Million
0.0% of portfolio
|
Q3 2025
Added 29.92%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,276,766
shares
|
$82.9 Million
0.0% of portfolio
|
Q3 2025
Added 7.01%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
1,262,182
shares
|
$82 Million
0.01% of portfolio
|
Q2 2025
Added 245.62%
|
|
|
Jennison Associates LLC
|
Oct 30, 2025 Q3 2025 |
1,027,739
shares
|
$66.7 Million
0.03% of portfolio
|
Q3 2025
Added 24.57%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
939,094
shares
|
$61 Million
0.45% of portfolio
|
Q3 2025
Added 0.56%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2025 Q3 2025 |
863,762
shares
|
$56.1 Million
0.01% of portfolio
|
Q3 2025
Added 5.47%
|
|
|
Holocene Advisors, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
840,333
shares
|
$54.6 Million
0.12% of portfolio
|
Q3 2025
New holding
|
|
|
Commodore Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
750,000
shares
|
$48.7 Million
2.71% of portfolio
|
Q2 2025
New holding
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
731,420
shares
|
$47.5 Million
0.01% of portfolio
|
Q3 2025
Added 29.83%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
711,444
shares
|
$46.2 Million
0.01% of portfolio
|
Q3 2025
Added 155.24%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
648,718
shares
|
$42.1 Million
0.01% of portfolio
|
Q3 2025
Added 16.31%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2025 Q3 2025 |
644,590
shares
|
$41.9 Million
0.67% of portfolio
|
Q3 2025
Added 14.49%
|
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Nov 14, 2025 Q3 2025 |
615,091
shares
|
$39.9 Million
0.12% of portfolio
|
Q3 2025
Added 1130.18%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
611,221
shares
|
$39.7 Million
0.02% of portfolio
|
Q3 2025
Added 574.43%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2025 Q3 2025 |
572,258
shares
|
$37.2 Million
0.6% of portfolio
|
Q3 2025
Reduced 12.36%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 03, 2025 Q3 2025 |
558,700
shares
|
$36.3 Million
0.06% of portfolio
|
Q3 2025
New holding
|
|